These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2901082)

  • 1. Pharmacokinetics of neuroleptic drugs and the utility of plasma level monitoring.
    Dahl SG
    Psychopharmacol Ser; 1988; 5():34-46. PubMed ID: 2901082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG
    Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic plasma levels.
    Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
    Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.
    Juenke JM; Brown PI; Urry FM; Johnson-Davis KL; McMillin GA
    Clin Chim Acta; 2013 Aug; 423():32-4. PubMed ID: 23618971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma level monitoring of antipsychotic drugs.
    Cooper TB
    Clin Pharmacokinet; 1978; 3(1):14-38. PubMed ID: 25154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The strategy and value of neuroleptic drug monitoring.
    Curry SH
    J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():49-57. PubMed ID: 26660173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
    Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
    Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.
    Balant-Gorgia AE; Balant L
    Clin Pharmacokinet; 1987 Aug; 13(2):65-90. PubMed ID: 2887326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.
    Dahl SG
    Ther Drug Monit; 1982; 4(1):33-40. PubMed ID: 6122292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
    Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
    J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants.
    Yoshida K; Smith B; Craggs M; Kumar R
    Psychol Med; 1998 Jan; 28(1):81-91. PubMed ID: 9483685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of neuroleptics: state of the art.
    Simpson GM; Yadalam K
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relations between the levels of neuroleptics and the doses, the therapeutic effects and the side effects].
    Davy JP; Moulin M; Andersson JC; Halbecq JJ; Morel P; Poilpre E
    Encephale; 1978; 4(4):293-321. PubMed ID: 33791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance.
    Altamura AC
    Schizophr Res; 1993 Jan; 8(3):187-98. PubMed ID: 8094628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
    Kendler KS; Davis KL
    Psychiatry Res; 1984 Sep; 13(1):51-8. PubMed ID: 6151204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.